Skip to content

Public FDA record

Z-0346-04: Healon GV, 14 mg per mL, Sodium Hyaluronate, 0.55 ml each, supplied with sterile single-use cannula, Rx o

Recall record Z-0346-04 for Cardinal Health. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0346-04
Company in FDA record
Cardinal Health
FDA classification date
Jan 14, 2004
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

The product was not held at the labeled storage temperatures, which could affect the product potency and/or physical properties, were distributed.

Source facts

Action
The firm contacted their consignees on 12/11/2003 by telephone and letter.
Initiated
2003-12-11
Root cause
Other
Terminated
2004-04-08
Distribution
The product was distributed to customers in OH and PA.
Recall number
Z-0346-04
Recall status
Terminated
CDRH record ID
30988
FDA classified
2004-01-14
Recall event number
28002

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗